Independent commission asks MHRA to introduce staged authorization, continuous monitoring and tougher enforcement for AI ...

Multiple Chinese ventures including Xianbo, MagicRNA, Siran and Leaderna secure new funding to push ahead with early- or ...

Kendal says its “whole milk recipe” exclusivity claim, which it withdrew during the review, was accurate when its Kendalmil ...

A drop in new molecular entity application reviews, as well as their costs, led to another decrease in the US ...

Built around five BMS pipeline assets and financed by Bain Capital, Beeline has TLR7/8 inhibitor afimetoran successfully ...

The National Pharmaceutical Council identified three drugs that could be selected in the next round of Medicare price ...

Rx-to-OTC switch is stalling in the US, with regulatory unpredictability discouraging manufacturers and holding back the ...

With $225m in fresh funding, the company will soon start enrolling patients in a study of porustobart in MSS colon cancer, ...

Raza spent more than 35 years at the FDA, including four years as chief counsel, before retiring from the agency in spring ...

Patients are increasingly empowered by the ability to use AI to control their healthcare journeys. A landmark three-country ...

Structure's oral amylin ACCG-2671 drove up to 3.3% weight loss in its first human trial, but dose-related nausea and a modest ...

Evidence is growing for digital measures of cognitive decline including speech tracking, eye movements and spatial navigation – but pharma skepticism remains.